Autopsy report · NCT02160704

Androxal in Male Infertility

“Difficult eligibility and lack of funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2, Phase 3

Sponsor

Baylor College of Medicine

Sponsor type

University, hospital or other

Conditions

Infertility

Interventions

Enclomiphene citrate; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis
  “Difficulty finding eligible participants and lack of funding.” (83% match in meaning)
• Cooling to Optimize Organ Life in Donor Study
  “Lack of funding and other logistic reasons” (77% match in meaning)
• Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
  “Poor enrollment, lack of feasibility” (76% match in meaning)
• Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
  “lack of funding/ benefit” (76% match in meaning)
• Systematic Work Environment Model Incorporating Web-based Neck-specific Exercise for Dental Staff With Neck Pain
  “Lack of fundings” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.